Biotechnology, Pharmaceuticals, and Healthcare by Arrowhead Pharmaceuticals

  • Sholanke Dele
  • 11.06.2026
Arrowhead Pharmaceuticals trades near $70 support amid conference participation and weak momentum
Arrowhead Pharmaceuticals announced it will participate in the NLASessions event from June 11 to 14 at the Sheraton Grand Chicago Riverwalk.Arrowhead Pharmaceuticals invited attendees to stop by ...
  • Igor Krasulya
  • 01.12.2025
Arrowhead Pharmaceuticals celebrates FDA approval for new rare disease therapy
Arrowhead Pharmaceuticals has achieved a significant milestone with the FDA approval of its new therapy designed to lower triglycerides for adults suffering from Familial Chylomicronemia Syndrome ...